Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
NVIDIA
NVDA
5
Broadcom
AVGO
US Stock MarketDetailed Quotes
Nurix Therapeutics (NRIX)
- 18.860
- -0.180-0.95%
Close Jan 15 15:59 ET
- 18.860
- 0.0000.00%
Post 18:05 ET
1.91BMarket Cap-6.35P/E (TTM)
19.300High18.610Low890.72KVolume19.010Open19.040Prev Close16.83MTurnover0.95%Turnover RatioLossP/E (Static)101.36MShares22.50052wk High5.13P/B1.78BFloat Cap8.18052wk Low--Dividend TTM94.18MShs Float52.380Historical High--Div Yield TTM3.62%Range %4.220Historical Low18.890Avg Price1Lot Size
Nurix Therapeutics (NRIX) Income Statement
Quarterly+Annual
YOY
| (Q3)Aug 31, 2025 | (Q2)May 31, 2025 | (Q1)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -37.29%7.89M | 264.34%44.06M | 11.26%18.45M | -29.15%54.55M | -12.37%13.28M | -31.84%12.59M | -60.58%12.09M | 30.74%16.59M | 99.31%76.99M | 123.49%15.16M |
| Operating revenue | -37.29%7.89M | 264.34%44.06M | 11.26%18.45M | -29.15%54.55M | -12.37%13.28M | -31.84%12.59M | -60.58%12.09M | 30.74%16.59M | 99.31%76.99M | 123.49%15.16M |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 47.74%99.28M | 52.36%92.38M | 31.57%81.32M | 15.31%267.58M | 28.84%77.94M | 14.91%67.2M | 5.56%60.63M | 11.08%61.8M | 4.29%232.05M | 9.05%60.49M |
| Selling and administrative expenses | 12.30%13.16M | 21.96%14.28M | -1.23%11.65M | 7.09%45.94M | -0.58%10.72M | 10.31%11.72M | 0.27%11.71M | 20.14%11.8M | 12.91%42.9M | 15.08%10.78M |
| -General and administrative expense | 12.30%13.16M | 21.96%14.28M | -1.23%11.65M | 7.09%45.94M | -0.58%10.72M | 10.31%11.72M | 0.27%11.71M | 20.14%11.8M | 12.91%42.9M | 15.08%10.78M |
| Research and development costs | 55.22%86.12M | 59.63%78.1M | 39.31%69.66M | 17.17%221.63M | 35.22%67.22M | 15.93%55.48M | 6.90%48.92M | 9.14%50.01M | 2.52%189.15M | 7.82%49.71M |
| Operating profit | -67.34%-91.39M | 0.45%-48.32M | -39.02%-62.86M | -37.38%-213.03M | -42.62%-64.66M | -36.49%-54.61M | -81.36%-48.54M | -5.28%-45.22M | 15.67%-155.06M | 6.89%-45.33M |
| Net non-operating interest income expense | -13.47%4.96M | 37.56%5.62M | 71.80%6.51M | 77.49%19.73M | 81.05%6.12M | 89.34%5.74M | 64.15%4.08M | 70.84%3.79M | 216.94%11.12M | 71.21%3.38M |
| Non-operating interest income | -13.47%4.96M | 37.56%5.62M | 71.80%6.51M | 77.49%19.73M | 81.05%6.12M | 89.34%5.74M | 64.15%4.08M | 70.84%3.79M | 216.94%11.12M | 71.21%3.38M |
| Other net income (expense) | ||||||||||
| Income before tax | -76.82%-86.42M | 3.94%-42.7M | -36.02%-56.35M | -34.28%-193.3M | -39.53%-58.54M | -32.16%-48.87M | -83.12%-44.46M | -1.71%-41.43M | 20.19%-143.95M | 10.19%-41.96M |
| Income tax | 0 | 744.44%760K | 0 | 270K | 8K | 82K | 90K | 90K | 0 | 0 |
| Net income | -76.53%-86.42M | 2.43%-43.46M | -35.73%-56.35M | -34.47%-193.57M | -39.55%-58.55M | -32.38%-48.96M | -83.49%-44.55M | -1.93%-41.52M | 20.19%-143.95M | 10.19%-41.96M |
| Net income continuous Operations | -76.53%-86.42M | 2.43%-43.46M | -35.73%-56.35M | -34.47%-193.57M | -39.55%-58.55M | -32.38%-48.96M | -83.49%-44.55M | -1.93%-41.52M | 20.19%-143.95M | 10.19%-41.96M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -76.53%-86.42M | 2.43%-43.46M | -35.73%-56.35M | -34.47%-193.57M | -39.55%-58.55M | -32.38%-48.96M | -83.49%-44.55M | -1.93%-41.52M | 20.19%-143.95M | 10.19%-41.96M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -76.53%-86.42M | 2.43%-43.46M | -35.73%-56.35M | -34.47%-193.57M | -39.55%-58.55M | -32.38%-48.96M | -83.49%-44.55M | -1.93%-41.52M | 20.19%-143.95M | 10.19%-41.96M |
| Basic earnings per share | -53.73%-1.03 | 26.76%-0.52 | 11.84%-0.67 | -8.68%-2.88 | 2.60%-0.75 | 1.47%-0.67 | -57.78%-0.71 | -1.33%-0.76 | 28.57%-2.65 | 11.49%-0.77 |
| Diluted earnings per share | -53.73%-1.03 | 26.76%-0.52 | 11.84%-0.67 | -8.68%-2.88 | 2.60%-0.75 | 1.47%-0.67 | -57.78%-0.71 | -1.33%-0.76 | 28.57%-2.65 | 11.49%-0.77 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Market Insights
Nancy Pelosi Portfolio Nancy Pelosi Portfolio
Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns. Former U.S. House Speaker Pelosi, renowned as the "Stock Market Queen" in politics, concentrates her investment portfolio on tech giants in AI and semiconductors. Her core strategy involves purchasing call options for leveraged trading to maximize potential returns.
China Concept Stocks China Concept Stocks
Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation. Chinese Concept Stocks refer to companies with core operations and revenue from Mainland China, listed on U.S. exchanges. They serve as a key bridge for global investors to access China's growth and innovation.
View More
Hot Topics Hot Topics
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec
今日熱門
Dec 11, 2025 03:27
December FOMC Interest Rate Meeting
牛牛課堂
Dec 19, 2025 12:28
[Opportunity Express] MRVL Continues to Bet on Optical Interconnects: Is Now a Good Time to Enter the Market?